Daniel Tondera

Company: Pantherna Therapeutics

Job title: Head of Biology

Seminars:

Panel Discussion: Overviewing the Greatest Risks Posed by Lipid Nanoparticles to Mitigate Adverse Affect Occurence 2:30 pm

Sharing insights into the adverse affects recorded across the literature and triaging the common causes of such events Spotlighting steps of formulation which require greatest attention to control the toxicity profile of the LNP Considering bioaccumulation of LNPs and the types of therapeutics and target sites which increase this riskRead more

day: Conference Day One

Evaluating the Role of Lipid Components in Targeted Delivery, Specifically Acknowledging the Helper Lipid as a Key Component to Success 11:00 am

Brand New Data! Investigating lipid components in isolation to understand the extent of the role it has on targeted delivery Reviewing the location of the lipid component and how this impacts delivery outcomes, including internal or external pretrusion from the surface of the lipid nanoparticles Spotlighting the mechanisms of action as a result of the…Read more

day: Conference Day One